Evogene (EVGN) Misses Q4 EPS by 3c

Evogene (NASDAQ: EVGN) reported Q4 EPS of ($0.20), $0.03 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $237 thousand versus the consensus estimate of $270 thousand.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Evogene Reports Second Quarter and First Half 2026 Financial Results
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
• Nvidia and Broadcom earnings: TD Cowen says earnings won’t settle big questions